Stock 300396 DIRUI INDUSTRIAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Dirui Industrial Co.,Ltd.

Equities

300396

CNE100001XS7

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
26.01 CNY +0.04% Intraday chart for Dirui Industrial Co.,Ltd. +5.52% -11.68%
18/04 Dirui Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
12/03 Dirui Industrial Gets Nod to Register 19 Devices MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's profit outlook over the next few years is a strong asset.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
DIRUI INDUSTRIAL CO.,LTD. Stock Dirui Industrial Co.,Ltd.
-11.68% 980M -
BIOMÉRIEUX Stock bioMérieux
-1.89% 12.56B
B+
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.68B
B-
DIASORIN S.P.A. Stock DiaSorin S.p.A.
-1.31% 5.29B
B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+21.82% 5.18B
C
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
C
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.89% 3.29B
D+
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.6B - -
VITROLIFE AB Stock Vitrolife AB
-10.02% 2.2B
B-
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.79B
D+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 300396 Stock
  4. Ratings Dirui Industrial Co.,Ltd.